Finance

Beta
Lists
ANVS:NYSE
Annovis Bio Inc
$1.72
+4.24%
(+0.070) 1D
$1.74
+1.42% (+0.025)
After hours
Closed: Jun 26, 4:00:11 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
$1.66
High
$1.72
Low
$1.65
Mkt. cap
59.59M
Avg. vol.
1.20M
Volume
1.36M
52-wk high
$5.50
52-wk low
$1.54
EPS
-$1.70
Beta
1.27
Shares outstanding
42.54M
No. of employees
8
Open
$1.66
High
$1.72
Low
$1.65
Mkt. cap
59.59M
Avg. vol.
1.20M
Volume
1.36M
52-wk high
$5.50
52-wk low
$1.54
EPS
-$1.70
Beta
1.27
Shares outstanding
42.54M
No. of employees
8
News stories
From sources across the web
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteannovisbio.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANVS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current $1.72
$17.00 (+888.37%)
Average
$12.50 (+626.74%)
Lowest
$8.00 (+365.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Reiterated
$8.00
+365.1%
05/28/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$17.00
+888.4%
04/14/2026
Last report
May 15, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.63 / -$0.36
-75.00%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.16M
6.29M
8.75M
16.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.11M
1.14M
955.15K
1.19M
Operating expense
6.27M
7.43M
9.71M
17.91M
Total operating expenses
6.27M
7.43M
9.71M
17.91M
Operating income
-6.27M
-7.43M
-9.71M
-17.91M
Other non operating income
-140.00K
20.00K
-296.00K
268.00K
EBT including unusual items
-6.22M
-7.26M
-9.83M
-17.61M
EBT excluding unusual items
-6.22M
-7.26M
-9.83M
-17.51M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.22M
-7.26M
-9.83M
-17.61M
Net profit margin
-
-
-
-
Earnings per share
-0.32
-0.37
-0.39
-0.63
Interest and investment income
191.40K
152.32K
167.74K
137.80K
Interest expense
-
-
-
-
Net interest expenses
191.40K
152.32K
167.74K
137.80K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of ANVS
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer